Royal Bank of Canada
CMTA

Royal Bank of Canada’s Clementia Pharmaceuticals Inc. CMTA Stock Holding History

Royal Bank of Canada’s Portfolio CMTA Stock Details CMTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-14
Closed – – 7447
2018
Q3 		$0 Hold
14
– – ﹤0.01% 7160
2018
Q2 		$0 Buy
14
+10
+250% +$162 ﹤0.01% 6966
2018
Q1 		$0 Sell
4
-3
-43% -$49 ﹤0.01% 7103
2017
Q4 		$0 Buy
+7
New +$117 ﹤0.01% 7174

Other funds holding CMTA

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Royal Bank of Canada's CMTA Position: Q4 2018 in Review

Royal Bank of Canada sold out of Clementia Pharmaceuticals Inc. (CMTA) in Q4 2018, closing a stake of 14 shares.

Royal Bank of Canada first reported a position in CMTA in Q4 2017 and held it in 4 quarters. The position peaked at $0 in Q3 2018. 31 funds tracked by Wall St. Rank hold CMTA as of Q4 2018.

  • Royal Bank of Canada reported no remaining Clementia Pharmaceuticals Inc. position as of Q4 2018 after selling out during the quarter.
  • Royal Bank of Canada sold 14 Clementia Pharmaceuticals Inc. shares in Q4 2018.
  • Royal Bank of Canada first reported a position in Clementia Pharmaceuticals Inc. in Q4 2017 and held it in 4 quarters.
  • Royal Bank of Canada's Clementia Pharmaceuticals Inc. position peaked at $0 in Q3 2018.
  • 31 funds tracked by Wall St. Rank held Clementia Pharmaceuticals Inc. as of Q4 2018.

Based on Royal Bank of Canada's 13F filing for Q4 2018, filed 14 Feb 2019.